CORCIONE, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 9.323
AS - Asia 6.511
EU - Europa 5.720
SA - Sud America 1.566
AF - Africa 265
OC - Oceania 118
Continente sconosciuto - Info sul continente non disponibili 29
Totale 23.532
Nazione #
US - Stati Uniti d'America 9.026
SG - Singapore 2.402
IT - Italia 1.908
CN - Cina 1.882
BR - Brasile 716
DE - Germania 530
IE - Irlanda 492
SE - Svezia 465
VN - Vietnam 380
FR - Francia 377
PE - Perù 350
IN - India 334
KR - Corea 304
FI - Finlandia 283
GB - Regno Unito 268
ES - Italia 264
HK - Hong Kong 188
AR - Argentina 184
DK - Danimarca 179
TR - Turchia 174
UA - Ucraina 160
ID - Indonesia 154
CL - Cile 144
NL - Olanda 134
AT - Austria 127
MX - Messico 124
CA - Canada 122
JP - Giappone 116
PL - Polonia 110
AU - Australia 106
BE - Belgio 82
RU - Federazione Russa 76
IR - Iran 67
CO - Colombia 65
SA - Arabia Saudita 60
TH - Thailandia 60
ZA - Sudafrica 55
TW - Taiwan 53
GR - Grecia 52
EC - Ecuador 45
RO - Romania 38
EG - Egitto 37
PK - Pakistan 36
BD - Bangladesh 33
MA - Marocco 32
TN - Tunisia 32
MY - Malesia 31
CH - Svizzera 30
PH - Filippine 30
PT - Portogallo 28
CZ - Repubblica Ceca 24
BO - Bolivia 23
MN - Mongolia 23
EU - Europa 20
CR - Costa Rica 19
IL - Israele 19
JO - Giordania 19
LB - Libano 18
KE - Kenya 17
KZ - Kazakistan 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
PY - Paraguay 16
ET - Etiopia 15
IQ - Iraq 15
LV - Lettonia 14
NG - Nigeria 14
QA - Qatar 13
VE - Venezuela 13
SI - Slovenia 12
NZ - Nuova Zelanda 11
UG - Uganda 11
PS - Palestinian Territory 10
UY - Uruguay 10
AZ - Azerbaigian 9
BA - Bosnia-Erzegovina 9
DZ - Algeria 9
NO - Norvegia 9
BG - Bulgaria 8
NP - Nepal 8
AP - ???statistics.table.value.countryCode.AP??? 7
HU - Ungheria 7
MU - Mauritius 6
DO - Repubblica Dominicana 5
GH - Ghana 5
GT - Guatemala 5
HN - Honduras 5
MD - Moldavia 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
HR - Croazia 4
LT - Lituania 4
LU - Lussemburgo 4
LY - Libia 4
BY - Bielorussia 3
CY - Cipro 3
MR - Mauritania 3
OM - Oman 3
PA - Panama 3
Totale 23.473
Città #
Singapore 1.283
Chandler 972
Santa Clara 755
Ashburn 681
Beijing 538
Houston 487
Dublin 484
Ann Arbor 478
Fairfield 421
Torino 297
Turin 263
Seoul 251
Lima 246
Hefei 245
Nyköping 193
Columbus 185
Wilmington 178
Woodbridge 171
Dallas 165
Milan 146
Munich 145
Seattle 141
Cambridge 138
Medford 138
Los Angeles 134
Villeurbanne 126
Princeton 125
Jakarta 115
Hong Kong 113
Redwood City 113
Bengaluru 104
Pisa 99
Guangzhou 95
Dearborn 86
Lappeenranta 85
New York 85
Rome 83
Vienna 82
Buffalo 81
Warsaw 81
Fremont 80
Hangzhou 80
Dong Ket 79
Ho Chi Minh City 77
Jacksonville 76
Santiago 74
Shanghai 71
Boston 64
Boardman 62
Redondo Beach 60
Brussels 58
Helsinki 57
Madrid 56
São Paulo 50
Hanoi 49
Turku 48
Paris 47
Buenos Aires 46
Hebei 46
San Diego 46
London 45
Nuremberg 44
Ankara 42
Barcelona 42
Frankfurt am Main 39
Istanbul 38
Nanjing 38
Tokyo 37
Mexico City 35
Chengdu 34
Silver Spring 33
Washington 32
Central 28
Chennai 28
Fuzhou 26
Padova 25
Palermo 25
Riyadh 25
San Miguel de Tucumán 25
Toronto 25
Brooklyn 24
Bogotá 23
Norwalk 23
Philadelphia 23
Sydney 23
Rio de Janeiro 22
Amsterdam 21
Arequipa 21
Bangkok 21
Chicago 21
Düsseldorf 21
Huancayo 21
Phoenix 21
Denver 20
Fortaleza 20
Johannesburg 20
Mumbai 20
Naples 20
New Delhi 20
Ulan Bator 20
Totale 12.925
Nome #
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review 1.898
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation 983
Antimicrobial prophylaxis in minor and major surgery. 633
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study 441
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 382
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. 380
Re-defining tigecycline therapy 347
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? 330
Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results 291
Antimicrobial stewardship in a long-term acute care hospital using offsite electronic medical record audit 289
Health-care Associated KPC-BSI: The Time Has Come. 274
Anidulafungin for Candida glabrata Infective Endocarditis 273
High rate of respiratory MDR gram-negative bacteria in H1N1-ARDS treated with ECMO. 272
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH 254
Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection 254
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome 230
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation? 224
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis 216
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. 210
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 209
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study 206
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 206
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. 201
Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study 191
PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE 189
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. 184
Start Smart with Antimicrobial Stewardship 176
Surgical antimicrobial prophylaxis prescribing practices and impact on infection risk: Results from a multicenter surveillance study in Italy (2012-2017) 171
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis 167
Clinical pharmacology of complex regiment of antiretroviral therapy including Etravirine, Maraviroc and Raltégravir. 166
The effect on mortality of fluconazole or echinocandins treatment in internal medicine wards 165
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project 165
From ESKAPE to ESCAPE, From KPC to CCC. 150
Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients 149
A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: Beyond the ICU 148
Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci 147
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 146
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 143
Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital. 140
Pharmacokinetics of Meropenem in Burn Patients with Infections Caused by Gram Negative Bacteria: Are We Getting Close to the Right Treatment? 140
Wound botulism after traumatic open fracture in Italy 138
Mortality in early- and late-onset candidemia 136
Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: the Turin bundle 134
A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course and outcome 132
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball 132
The "scar" of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy 131
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study 131
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 128
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 126
Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry 126
First case of E. meningoseptica in Italy in a patient with necrotic hemorrhagic pancreatitis 125
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 123
Enteropathogenetic nosocomial infections: predisposing clinical characteristics and risk of recurrent infections 122
A Common mdr1 Gene Polymorphism is Associated with Changes in Linezolid Clearance 113
Choosing wisely: what's the actual role of antimicrobial stewardship in intensive care units? 112
Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy 112
Neurological disease may precede lymphadenopathies in Actinomyces europaeus infection 111
Cost‐effectiveness analysis of the prophylactic use of ertapenem for the prevention of surgical site infections after elective colorectal surgery 111
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots 110
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 109
Antibiotic de-escalation experience in the setting of emergency department: A retrospective, observational study 106
Pharmacokinetics of high dosage of linezolid in two morbidly obese patients-authors' response 105
Pharmacogenomic influence on sepsis outcome in critically ill patients 105
A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold 103
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience 103
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 102
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements 102
Staphylococcus aureus producing Panton-Valentine Leukocidin: An emerging problem in Italian ICUs 100
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study 99
Real-life use of isavuconazole outside the hematological wards. 99
Pharmacokinetics of high dosage of linezolid in two morbidly obese patients 98
New cephalosporins for the treatment of pneumonia in internal medicine wards 98
Erratum to Pharmacokinetics of high dosage of linezolid in two morbidly obese patients [J Antimicrob Chemother, (2015), 70, 2417-2418] 98
Carbapenemase-producing klebsiella pneumoniae colonization and infection in solid organ transplant recipients: A single-center, retrospective study 98
COVID-19: A Possible Contribution of the MAPK Pathway 97
Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata 97
The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience 95
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage 95
Impact of an empiric antimicrobial therapy manual on antimicrobial usage and multidrug resistant organism trends in a large Italian teaching hospital 94
Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes? 94
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 94
Ceftazidime-avibactam susceptible to resistant KPC-producing Enterobacterales bloodstream infections: an observational study 94
Use of colistin in adult patients: A cross-sectional study 94
Oral neomycin and bacitracin are effective in preventing surgical site infections in elective colorectal surgery: a multicentre, randomized, parallel, single-blinded trial (COLORAL-1) 92
Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach 92
An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs. 91
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 90
Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study 90
Pharmacokinetic of caspofungin in patients with invasive candidiasis 89
Guida Lippincott alle Malattie Infettive 89
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 89
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 89
First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy 88
Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score 86
Ozone therapy in COVID-19: A narrative review 85
Current and future therapies for invasive aspergillosis. 84
Liver transplantation with an uncommon full right hemiliver graft after hydatid cysts resection: Case report and review of the literature 84
Skin and soft tissue infections after breast surgery 83
Point prevalence data on antimicrobial usage in Italian acute-care hospitals: Evaluation and comparison of results from two national surveys (2011-2016) 83
Epidemiology, prevalence and risk factors for infections in burn patients: results from a regional burn centre’s analysis 83
Totale 17.959
Categoria #
all - tutte 77.494
article - articoli 0
book - libri 0
conference - conferenze 1.379
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.278 0 0 0 0 114 78 87 77 123 240 181 378
2021/20222.451 183 145 174 189 171 211 150 137 129 164 434 364
2022/20233.635 312 294 211 324 314 715 220 277 387 145 250 186
2023/20242.368 239 353 128 148 187 218 153 163 76 215 213 275
2024/20255.859 220 372 371 412 1.020 485 248 299 572 445 507 908
2025/20264.104 1.123 736 745 1.301 199 0 0 0 0 0 0 0
Totale 24.168